Michael P. Hefferan

Mike P. Hefferan, PhD has extensive work experience in the field of neuroscience and pharmacology. Michael (Mike) P. is currently the Director and Head of in vivo Pharmacology at Tune Therapeutics. Prior to this position, they served as the Associate Director of Neuroscience, Pharmacology, and Translational Biology at Voyager Therapeutics, Inc.

Before joining Voyager Therapeutics, Inc., Mike worked as a Senior Scientist in Biology and Preclinical Sciences at Celgene. Michael (Mike) P. also served as a Principal Scientist at Neuralstem, Inc. for several years.

Mike's career began at the University of California, San Diego where they held various roles, including Project Scientist and Post-doctoral Fellow. In these positions, they managed and performed major projects focused on demonstrating the effectiveness of human neural stem cells in amyotrophic lateral sclerosis. Michael (Mike) P. also conducted research on the mechanisms of muscle spasticity following spinal ischemic injury and collaborated with pharmaceutical companies in the development of potential therapies.

Overall, Mike Hefferan's work experience demonstrates a strong background in neuroscience, pharmacology, and preclinical research.

Michael (Mike) P. Hefferan, PhD has an extensive education history. Michael (Mike) P. began their academic journey at Queen's University from 1992 to 1996, where they earned a Bachelor of Science (BSc) in Engineering. Michael (Mike) P.'sstudies focused on Engineering Chemistry and Chemical Engineering.

Following their undergraduate degree, Hefferan pursued a higher level of education at Memorial University of Newfoundland. From 1998 to 2003, they successfully completed their Doctor of Philosophy (Ph.D.) in Neuroscience and Pharmacology.

Continuing their intellectual pursuits, from 2003 to 2007, Hefferan joined UC San Diego as a Post-Doctoral Fellow. During this period, they devoted their research to the investigation of Neurodegenerative diseases and therapy development.

Collectively, these educational experiences reflect Hefferan's dedication to the fields of Engineering Chemistry, Chemical Engineering, Neuroscience, and Pharmacology. Michael (Mike) P.'sbroad academic background sets the foundation for their expertise in neurodegenerative diseases and therapy development.